rs2598044

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_016616.5(NME8):​c.177C>T​(p.Asp59Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.244 in 1,605,020 control chromosomes in the GnomAD database, including 49,984 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6014 hom., cov: 33)
Exomes 𝑓: 0.24 ( 43970 hom. )

Consequence

NME8
NM_016616.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.953

Publications

16 publications found
Variant links:
Genes affected
NME8 (HGNC:16473): (NME/NM23 family member 8) This gene encodes a protein with an N-terminal thioredoxin domain and three C-terminal nucleoside diphosphate kinase (NDK) domains, but the NDK domains are thought to be catalytically inactive. The sea urchin ortholog of this gene encodes a component of sperm outer dynein arms, and the protein is implicated in ciliary function. Mutations in this gene are implicated in primary ciliary dyskinesia type 6.[provided by RefSeq, Nov 2009]
NME8 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia 6
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 7-37850714-C-T is Benign according to our data. Variant chr7-37850714-C-T is described in ClinVar as Benign. ClinVar VariationId is 164799.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.953 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NME8NM_016616.5 linkc.177C>T p.Asp59Asp synonymous_variant Exon 5 of 18 ENST00000199447.9 NP_057700.3 Q8N427

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NME8ENST00000199447.9 linkc.177C>T p.Asp59Asp synonymous_variant Exon 5 of 18 1 NM_016616.5 ENSP00000199447.4 Q8N427
ENSG00000290149ENST00000476620.1 linkc.-109-6560C>T intron_variant Intron 1 of 3 4 ENSP00000425858.1 D6RIH7

Frequencies

GnomAD3 genomes
AF:
0.275
AC:
41818
AN:
151936
Hom.:
6003
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.158
Gnomad AMR
AF:
0.250
Gnomad ASJ
AF:
0.280
Gnomad EAS
AF:
0.180
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.245
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.257
GnomAD2 exomes
AF:
0.229
AC:
57476
AN:
250792
AF XY:
0.224
show subpopulations
Gnomad AFR exome
AF:
0.374
Gnomad AMR exome
AF:
0.203
Gnomad ASJ exome
AF:
0.282
Gnomad EAS exome
AF:
0.185
Gnomad FIN exome
AF:
0.236
Gnomad NFE exome
AF:
0.242
Gnomad OTH exome
AF:
0.236
GnomAD4 exome
AF:
0.241
AC:
349803
AN:
1452966
Hom.:
43970
Cov.:
31
AF XY:
0.238
AC XY:
172214
AN XY:
723382
show subpopulations
African (AFR)
AF:
0.370
AC:
12305
AN:
33254
American (AMR)
AF:
0.207
AC:
9237
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.281
AC:
7330
AN:
26072
East Asian (EAS)
AF:
0.183
AC:
7242
AN:
39656
South Asian (SAS)
AF:
0.138
AC:
11855
AN:
86138
European-Finnish (FIN)
AF:
0.235
AC:
12549
AN:
53372
Middle Eastern (MID)
AF:
0.237
AC:
1323
AN:
5574
European-Non Finnish (NFE)
AF:
0.248
AC:
273417
AN:
1104120
Other (OTH)
AF:
0.242
AC:
14545
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
13304
26608
39911
53215
66519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9204
18408
27612
36816
46020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.275
AC:
41860
AN:
152054
Hom.:
6014
Cov.:
33
AF XY:
0.272
AC XY:
20220
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.366
AC:
15162
AN:
41462
American (AMR)
AF:
0.250
AC:
3816
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.280
AC:
972
AN:
3468
East Asian (EAS)
AF:
0.180
AC:
934
AN:
5178
South Asian (SAS)
AF:
0.136
AC:
656
AN:
4818
European-Finnish (FIN)
AF:
0.245
AC:
2591
AN:
10556
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.250
AC:
16959
AN:
67970
Other (OTH)
AF:
0.256
AC:
541
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1549
3098
4647
6196
7745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.256
Hom.:
4231
Bravo
AF:
0.277
Asia WGS
AF:
0.164
AC:
571
AN:
3478
EpiCase
AF:
0.246
EpiControl
AF:
0.246

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asp59Asp in exon 5 of TXNDC3: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 36.8% (1622/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2598044). -

Primary ciliary dyskinesia 6 Benign:2
May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Dec 10, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.0
DANN
Benign
0.73
PhyloP100
-0.95
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2598044; hg19: chr7-37890316; COSMIC: COSV52250626; API